- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05503186
Text Intervention to Facilitate Secure Storage and Disposal of Prescription Opioids
April 2, 2026 updated by: Wake Forest University Health Sciences
Development and Pilot Randomized Control Trial of a Text Message Intervention to Facilitate Secure Storage and Disposal of Prescription Opioids to Prevent Diversion and Misuse
The proposed study aims to develop and implement a text message intervention that will instruct and motivate individuals to securely store opioid medications during treatment and subsequently dispose of unused medications following treatment.
It is relevant to public health as it is expected to meet the critical need of reducing the diversion of prescription opioids for nonmedical use.
The proposed research is relevant to National Institute on Drug Abuse's priorities to develop and implement theoretically based, prevention interventions that can be scalable in healthcare settings to elicit population-level impacts to address the opioid crisis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Drug overdoses are now the leading cause of injury-related death in the United States (US), 35% of which are due to nonmedical use of a prescribed opioid.
In the US, 3.3 million people aged 12 or older report past 30-day nonmedical prescription opioid use (NMPOU), defined as use of a prescribed opioid analgesic without a prescription or for reasons other than prescribed.
The existing supply of opioid analgesics is high; the prescribing rate equates to at least one opioid prescription per resident in the highest prescribing counties.
Many of these opioid analgesics are leftover following treatment and kept in homes rather than being disposed after ceasing use or expiration.
Over half of individuals who report NMPOU obtain prescription medications from a relative or friend, with or without their knowledge.
Thus, diversion of excess medication is the primary source of NMPOU.
Secure storage and disposal of unused opioid analgesics has been extensively promoted at the federal level and adopted by local communities as a strategy to combat diversion of NMPOU.
The premise underlying these two strategies is that (1) secure storage minimizes the likelihood of diversion while opioid analgesics are being used during treatment and (2) disposal programs provide opportunities for patients to remove unused or expired opioids outside the home, ultimately reducing availability for NMPOU.
However, recent evidence demonstrates that a majority of individuals do not securely store opioids analgesics and only a fraction of unused prescription opioids are disposed of through these take-back events and dropboxes.
This is likely due, in part, to a widespread failure of knowledge about and lack of motivation to securely storing and disposing unused prescription opioids.
There is evidence that increasing awareness of storage procedures and disposal mechanisms and targeted interventions delivered by healthcare systems may enhance secure storage and disposal of opioid medications.
Mobile phone text message reminders, a technology used to prompt multiple health behaviors, may address the need to provide timely guidance on proper handling of opioid medications by prompting patients to securely store and dispose unused prescription opioids.
Study Type
Interventional
Enrollment (Actual)
479
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest University Health Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 18 years or older
- able to read and speak English
- owning a cell phone with the capability of receiving short message service (SMS) text messages
- receiving an opioid prescription within the past 14 days
Exclusion Criteria:
- 17 years or younger
- not able to read and speak English
- does not own a cell phone with the capability of receiving SMS text messages
- has not received an opioid prescription within the past 14 days
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Text Message Intervention Study Condition
The intervention is a text message intervention.
Text messages will provide guidance on secure storage and disposal of prescription opioids to participants who have been dispensed a prescription opioid.
Participants in the intervention study condition will receive a series of text messages that aim to facilitate secure storage and disposal of unused opioid prescriptions.
|
The intervention consists of a series of text messages aimed to facilitate secure storage and disposal of unused opioid medications.
Information provided by the physician and/or pharmacist.
|
|
Active Comparator: Control Study Condition
Participants assigned to the control study condition will not receive the text message intervention.
Participants assigned to the control study condition will receive a standard of care of treatment which is whatever guidance that is provided to them by their physician and/or pharmacist.
|
Information provided by the physician and/or pharmacist.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Participants Who Securely Stored Their Opioid Medication During Treatment
Time Frame: 45 days following enrollment
|
Investigators will assess the differences in the percentage of participants who securely stored their opioid medication during treatment using a dichotomous, close-ended question on a self-administered questionnaire.
|
45 days following enrollment
|
|
Percentage of Participants Who Disposed of Their Unused Opioid Medication
Time Frame: 45 days following enrollment
|
Investigators will assess the differences in the percentage of participants who disposed of their unused opioid medication following completion of treatment using a dichotomous, close-ended question on a self-administered questionnaire.
|
45 days following enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Kathleen Egan, PhD, MS, Wake Forest University Health Sciences
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 14, 2024
Primary Completion (Actual)
December 9, 2024
Study Completion (Actual)
December 9, 2024
Study Registration Dates
First Submitted
April 12, 2022
First Submitted That Met QC Criteria
August 15, 2022
First Posted (Actual)
August 16, 2022
Study Record Updates
Last Update Posted (Actual)
April 22, 2026
Last Update Submitted That Met QC Criteria
April 2, 2026
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00102139
- UMCIRB 21-001307 (Other Identifier: UMC)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
After all data have been collected and the results of the study have been published, de-identified data will be made available to other qualified investigators upon request.
The request will be evaluated by the Principal Investigator to ensure that it meets reasonable demands of scientific inquiry.
Data collected for this study will be submitted and shared with the National Institute on Drug Abuse Data Archive per NOT-OD-03-032.
IPD Sharing Time Frame
After all data have been collected and the results of the study have been published.
IPD Sharing Access Criteria
De-identified data will be made available to other qualified investigators upon request.
The request will be evaluated by the Principal Investigator to ensure that it meets reasonable demands of scientific inquiry.
Data collected for this study will be submitted and shared with the National Institute on Drug Abuse Data Archive per NOT-OD-03-032.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Opioid Misuse
-
University of PennsylvaniaCompletedSurgery | Opioid Use | Opioid Misuse | Prescription Opioid MisuseUnited States
-
Knoa Pharma LLCPurdue Pharma LPCompleted
-
Thomas Jefferson UniversityCompletedPain | Opioid Misuse and AddictionUnited States
-
University of PittsburghNational Institute on Drug Abuse (NIDA)RecruitingOpioid Use Disorder | Opioid Use | Opioid Overdose | OpioidsUnited States
-
University of PennsylvaniaPublic Health Management Corporation; Philadelphia Department of Public Health and other collaboratorsCompleted
-
Cessation Therapeutics, Inc.Dr. Vince Clinical ResearchCompletedOpioid Use Disorder | Opioid OverdoseUnited States
-
The University of Texas Health Science Center,...RecruitingSubstance Use Disorders | Opioid Dependence | Opioid Use | Opioid-use Disorder | Opioid OverdoseUnited States
-
Michele StatonNational Institute on Drug Abuse (NIDA)Not yet recruitingOpioid Use Disorder | Stimulant Use Disorders | Overdose RiskUnited States
-
Duke UniversityNational Institute on Drug Abuse (NIDA)Not yet recruitingOpioid Use Disorder | Overdose | Overdose, Drug | Substance Use (Drugs, Alcohol)United States
-
University of OregonNational Institute on Drug Abuse (NIDA)RecruitingMiddle Schools | School Exclusion | School Community | Teaching Practices | Opioid and Other Substance MisuseUnited States
Clinical Trials on Text Message
-
University of California, San FranciscoUniversity of WashingtonCompleted
-
University of WashingtonUniversity of Illinois at Chicago; Kenya Medical Research InstituteCompletedHIV Infections | Acquired Immunodeficiency Syndrome | Circumcision, Male | Patient Compliance | Cellular PhoneKenya
-
Texas Tech University Health Sciences CenterTexas Tech UniversityCompletedBreast Cancer FemaleUnited States
-
University of WashingtonUniversity of California, San Francisco; Kenya Medical Research InstituteCompletedHIV Infections | Acquired Immunodeficiency SyndromeKenya
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Recruiting
-
Emory UniversityNational Cancer Institute (NCI)CompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Columbia UniversityPfizerCompletedVaccinationUnited States
-
Washington University School of MedicineThe Craig H. Neilsen FoundationRecruiting
-
Wake Forest University Health SciencesCompleted
-
New York City Health and Hospitals CorporationWithdrawn